Medindia

U.S. FDA approves KYGEVVI® (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)

UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that KYGEVVI® has been granted approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults and ...

Israel hands over bodies of 45 Palestinians after Hamas returns the remains of 3 soldiers

Israel handed over the bodies of 45 Palestinians on Monday, the Red Cross said, a day after militants returned<a class="excerpt-read-more" href=" More ...

Reimagining biocatalysis: Turning DNA phosphates into chiral catalysts

Chemists at the National University of Singapore (NUS) have found a new use for deoxyribonucleic acid (DNA), not just as ...

Powerful tool can map gene regulation at single-nucleotide resolution

Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...
News-Medical.Net on MSN

New approach harnesses tumor's own machinery to produce immune-stimulating molecules

By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers ...
India Today on MSN

CBSE 2025: Want full marks? Here's the new formula that works

CBSE has transformed its exam pattern to focus on competency and application. This shift challenges students and teachers to ...
Nature

‘Biotech Barbie’ says the time has come to consider CRISPR babies. Do scientists agree?

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

Specific human gene can help the heart repair itself from heart attack or heart failure

A naturally occurring gene called Cyclin A2 (CCNA2), which turns off after birth in humans, can actually make new, functioning heart cells and help the heart repair itself from injury, including a ...